trending Market Intelligence /marketintelligence/en/news-insights/trending/6qqpu9d8mmpjmekfrmc5ja2 content esgSubNav
In This List

Leap Therapeutics raises $16.1M via common stock offering

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Leap Therapeutics raises $16.1M via common stock offering

Leap Therapeutics Inc. raised $16.1 million in gross proceeds from the sale of 2,146,667 common shares in an underwritten public offering.

The shares sold included 280,000 shares sold pursuant to the full exercise of the underwriters' option to buy additional shares.

Raymond James & Associates Inc. and Ladenburg Thalmann acted as book-running managers for the offering.